Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Sixth Chamber) of 10 November 2021 –  
Stada Arzneimittel v EUIPO – Pfizer (RUXIMBLIS)

(Case T‑542/20)

(EU trade mark – Opposition proceedings – Application for the EU word mark RUXIMBLIS – Earlier EU word mark RUXIMERA – Relative ground for refusal – Likelihood of confusion – Similarity of the signs – Article 8(1)(b) of Regulation (EU) 2017/1001)

| 1. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 23, 24, 52) |

| 2. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Assessment of the likelihood of confusion – Determination of the relevant public – Attention level of the public  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 25, 57) |

| 3. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Similarity between the goods or services in question – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see para. 28) |

| 4. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Similarity of the marks concerned – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see para. 41) |

| 5. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services – Likelihood of confusion with the earlier mark – Word marks RUXIMBLIS and RUXIMERA  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paras 53-56, 58) |

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 16 June 2020 (Case R 1877/2019-4), relating to opposition proceedings between Pfizer and Stada Arzneimittel.

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders Stada Arzneimittel AG to pay the costs. |

[Top](#document1)